Product How it works Pricing Blog FAQ About Contact
Exelon

Exelon (NASDAQ: EXC) revenue

Exelon reported revenue of $24,258m for fiscal 2025, 5.3% more than in fiscal 2024 ($23,028m). Since fiscal 2016 its revenue has fallen by 22.7%, an average decline of 2.8% a year.

Revenue, in millions of US dollars31,366201633,558201735,978201834,438201916,663202017,938202119,078202221,727202323,028202424,2582025

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$24,258m+5.3%$5,148m21.2%
2024$23,028m+6.0%$4,319m18.8%
2023$21,727m+13.9%$4,023m18.5%
2022$19,078m+6.4%$3,315m17.4%
2021$17,938m+7.7%$2,682m15.0%
2020$16,663m−51.6%$2,191m13.1%
2019$34,438m−4.3%$4,374m12.7%
2018$35,978m+7.2%$3,891m10.8%
2017$33,558m+7.0%$4,388m13.1%
2016$31,366m—$3,212m10.2%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the revenue of Exelon

How much revenue did Exelon make in fiscal 2025?
Exelon reported revenue of $24,258m for fiscal 2025, compared with $23,028m in fiscal 2024.
How much has the revenue of Exelon fallen?
Between fiscal 2016 and fiscal 2025 it went from $31,366m to $24,258m: 22.7% less, an average decline of 2.8% a year.
What was the best year for revenue at Exelon?
Of its last 10 fiscal years, fiscal 2018, with $35,978m.
Where do the figures for Exelon come from?
From the annual report (Form 10-K) that Exelon files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Exelon files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Exelon: the Exelon page · annual accounts · net income · dividends paid · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.